Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
Mallinckrodt
US Department of Justice
Citi
UBS
Johnson and Johnson
McKesson
Accenture

Generated: May 20, 2018

DrugPatentWatch Database Preview

ORTHO-NOVUM 10-21 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Ortho-novum 10-21, and what generic alternatives are available?

Ortho-novum 10-21 is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.

The generic ingredient in ORTHO-NOVUM 10-21 is mestranol; norethindrone. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mestranol; norethindrone profile page.
Summary for ORTHO-NOVUM 10-21
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:ORTHO-NOVUM 10-21 at DailyMed
Drug patent expirations by year for ORTHO-NOVUM 10-21

US Patents and Regulatory Information for ORTHO-NOVUM 10-21

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Pharm ORTHO-NOVUM 10-21 mestranol; norethindrone TABLET;ORAL-21 012728-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Merck
Farmers Insurance
Accenture
Covington
Express Scripts
US Department of Justice
Federal Trade Commission
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.